Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia <i>In Vitro</i>.

Young, Alexander P; Szczesniak, Anna-Maria; Hsu, Karolynn; Kelly, Melanie E M; Denovan-Wright, Eileen M

Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia In Vitro.

Young, Alexander P; Szczesniak, Anna-Maria; Hsu, Karolynn; Kelly, Melanie E M; Denovan-Wright, Eileen M.

Afiliação

Young AP; Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
Szczesniak AM; Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
Hsu K; Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
Kelly MEM; Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
Denovan-Wright EM; Department of Ophthalmology & Visual Sciences, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.

ACS Pharmacol Transl Sci ; 7(5): 1348-1363, 2024 May 10.

Article em En | MEDLINE | ID: mdl-38751621

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article